CRYSTAL BRADLEY: Open Payments
NPI 1578024188 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 41 payments from 8 companies in 2025. Trend: 2023 $468 · 2024 $1,034 · 2025 $920
Food & beverage: $920
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $467 |
| Novo Nordisk Inc | 11 | $234 |
| Amgen Inc. | 3 | $55 |
| Exact Sciences Corporation | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| PFIZER INC. | 1 | $28 |
| Lilly USA, LLC | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: AIRSUPRA, FARXIGA, Ozempic, Rybelsus, BREZTRI, Cologuard Collection Kit, REXULTI, REPATHA.
Industry payments across TX — which companies pay providers there.
